LEADER 01225nam  2200409   450 
001 9910743342103321
005 20220925231153.0
010   $a981-16-7671-2
010   $a981-16-7672-0
010   $a981-16-7672-0
035   $a(MiAaPQ)EBC6882500
035   $a(Au-PeEL)EBL6882500
035   $a(CKB)21069312900041
035   $a(PPN)260831603
035   $a(EXLCZ)9921069312900041
100   $a20220925d2022      uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aHuman microbiome $eclinical implications and therapeutic interventions /$fedited by Sabu Thomas
210  1$aSingapore :$cSpringer,$d[2022]
210  4$dİ2022
215   $a1 online resource (269 pages)
311 08$aPrint version: Thomas, Sabu Human Microbiome Singapore : Springer Singapore Pte. Limited,c2022 9789811676710 
606   $aHuman body$xMicrobiology
615  0$aHuman body$xMicrobiology.
676   $a174.20973
702   $aThomas$b Sabu
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910743342103321
996   $aHuman Microbiome$92827084
997   $aUNINA